A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The aim of the study is to assess the efficacy of second and third line therapies (OFF vs. FOLFIRI) in a sequential cross-over design in patients pretreated with nab-paclitaxel/gemcitabine first line.
Epistemonikos ID: 70aa8c91cea5af9d4ef9cdc9ea03e2956331adda
First added on: May 21, 2024